Alnylam Uncovers Genetic Mutations in INHBE That Protect Against Abdominal Obesity
Go back to Alnylam Uncovers Genetic Mutations in INHBE That Protect Against Abdominal Obesity| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 232.75 -3.47 (1.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $236.22 | 52 Week High | $109.10 | |||
| Open | $235.83 | 52 Week Low | $31.38 | |||
| Day High | $236.80 | P/E | N/A | |||
| Day Low | $228.59 | EPS | $-1.45 | |||
| Volume | 1,091,332 | |||||
